- Ensuring care has the patient at the centre is a key aim for the NHS and something we’re particularly interested in at Anthony Nolan. Our post-transplant care pathway sets out one…
- Here, Anthony Nolan’s Chief Executive, Henny Braund, gives an overview of current and emerging treatments for blood cancer and the developments needed to give patients the best…
- Through the Anthony Nolan Cell & Gene Therapy Service’s provision of cellular material to cell and gene therapy researchers, we are familiar with industry standards and…
- The NHS Long-Term Plan commits to exploring new payment models to ensure that patients are able to receive the right care, in the right place, at the right time. The COVID-19…
- Our researchers are all dedicated to saving and improving the lives of patients with blood cancers and blood disorders. Our research portfolio covers every aspect…
- Since our research institute opened in 1996, We have made many scientific discoveries and established key initiatives that have transformed how transplants are performed world-…
- Our research into improving the transplant journey and developing new treatments is carried out across three sites in London and Nottingham. The Anthony Nolan Research…
- Our statement Anthony Nolan helps four people in need of a transplant a day, giving more people a second chance at life. But the charity won’t stop until all patients…
- When our charity began back in 1974, we relied on basic borrowed lab equipment to add donors to our register and stored their tissue type records in shoe boxes. Since these humble…
- Every day, our cord blood collectors are there at the births of new-born lifesavers. Bill Duffy, one of our collectors, explains what happens behind the scenes of the…
This page has been auto translated by Google Translate. Confirm any health information with your own medical team before acting upon it. All printed materials and PDFs are available in English only.